Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients
Clinical trial NCT01793077 · COMPLETED
Trial details
- NCT number
- NCT01793077
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.